Scope
2‐ and 3‐monochloropropanediol (2/3‐MCPD) and glycidol are absorbed in the intestine after lipase‐catalyzed hydrolysis of their fatty acid esters.
Methods and results
In an exposure study with 12 non‐smoking participants, the complete urinary excretion of the metabolite 2,3‐dihydroxypropylmercapturic acid (DHPMA) and of 2/3‐MCPD is measured on four consecutive days before and after consumption of 50 g glycidyl ester‐rich palm fat or 12 g 2/3‐MCPD ester‐rich hazelnut oil. After controlled exposure, urinary excretion rates of 2/3‐MCPD per hour strongly increase, followed by a decrease with average half‐lives of 5.8 h (2‐MCPD) and 3.6 h (3‐MCPD). After consumption of hazelnut oil, mean excretion rates are 14.3% (2‐MCPD) and 3.7% (3‐MCPD) of the study doses. The latter rate is significantly higher (4.6%) after consumption of palm fat, indicating partial conversion (about 5%) of glycidol to 3‐MCPD under the acidic conditions in the stomach. The average daily “background” exposure is estimated to be 0.12 and 0.32 µg per kg body weight (BW) for 2‐MCPD and 3‐MCPD, respectively. The relatively high and constant urinary excretion of DHPMA does not reflect the controlled exposure.
Conclusion
Urinary excretion of 2‐ and 3‐MCPD is suitable as biomarker for the external exposure to the respective fatty acid esters.